Ultrapure plasma factor VIII produced by anti-F VIII c immunoaffinity chromatography and solvent/detergent viral inactivation. Characterization of the Method M process and Hemofil M antihemophilic factor (human).
Baxter Hyland Division, Duarte, CA 91010.
M
M
Griffith
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D002846:Chromatography, Affinity; D003902:Detergents; D004340:Drug Contamination / Q000517:prevention & control; D005169:Factor VIII / Q000302:isolation & purification* / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007158:Immunologic Techniques; D017830:Octoxynol; D010755:Organophosphates; D011092:Polyethylene Glycols
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D003902:Detergents; D010755:Organophosphates; D011092:Polyethylene Glycols; D005169:Factor VIII; D017830:Octoxynol; C009524:tributyl phosphate